References
- Bhasin M, Raghava GP. (2004). Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine, 22, 3195–204
- Bright RA, Carter DM, Daniluk S, et al. (2007). Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine, 25, 3871–8
- Fleming DM, Elliot AJ. (2008). Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect, 136, 866–75
- Gessner JE, Heiken H, Tamm A, et al. (1998). The IgG Fc receptor family. Ann Hematol, 76, 231–48
- Heusser CH, Anderson CL, Grey HM. (1977). Receptors for IgG: Subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J Exp Med, 145, 1316–27
- Hossain MJ, Bourgeois M, Quan FS, et al. (2011). Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clin Vaccine Immunol, 18, 2010–17
- Huber VC, McKeon RM, Brackin MN, et al. (2006). Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol, 13, 981–90
- Itoh Y, Shinya K, Kiso M, et al. (2009). In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature, 460, 1021–5
- Kim MC, Song JM, O E, et al. (2013). Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus. Mol Ther, 21, 485–92
- Leigh MW, Connor RJ, Kelm S, et al. (1995). Receptor specificity of influenza virus influences severity of illness in ferrets. Vaccine, 13, 1468–73
- Liao YC, Lee MS, Ko CY, et al. (2008). Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics, 24, 505–12
- Naffakh N, van der Werf S. (2009). April 2009: An outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect, 11, 725–8
- Neuberger MS, Rajewsky K. (1981). Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol, 11, 1012–16
- Nimmerjahn F, Ravetch JV. (2005). Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science, 310, 1510–12
- Pence BD, Hester SN, Donovan SM, et al. (2012). Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice. Immunol Invest, 41, 275–89
- Perrone LA, Ahmad A, Veguilla V, et al. (2009). Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol, 83, 5726–34
- Quan FS, Kim MC, Lee BJ, et al. (2012). Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection. Virology, 430, 127–35
- Quan FS, Huang C, Compans RW, et al. (2007). Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol, 81, 3514–24
- Quan FS, Kim YC, Vunnava A, et al. (2010b). Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol, 84, 7760–9
- Quan FS, Steinhauer D, Huang C, et al. (2008). A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine, 26, 3352–61
- Quan FS, Vunnava A, Compans RW, et al. (2010a). Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One, 5, e9161
- Quan FS, Yoo DG, Song JM, et al. (2009). Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol, 83, 4489–97
- Ramshaw IA, Ramsay AJ. (2000). The prime-boost strategy: Exciting prospects for improved vaccination. Immunol Today, 21, 163–5
- Skibbe D, Zhou EM, Janke BH. (2004). Comparison of a commercial enzyme-linked immunosorbent assay with hemagglutination inhibition assay for serodiagnosis of swine influenza virus (H1N1) infection. J Vet Diagn Invest, 16, 86–9
- Song JM, Hossain J, Yoo DG, et al. (2010). Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology, 405, 165–75
- Wu A, Peng Y, Du X, et al. (2010). Correlation of influenza virus excess mortality with antigenic variation: Application to rapid estimation of influenza mortality burden. PLoS Comput Biol, 6(8):e1000882
- Xu R, Ekiert DC, Krause JC, et al. (2010). Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science, 328, 357–60